TY  - JOUR
AU  - Rodríguez-Portal, José Antonio
PY  - 2018
DO  - 10.1007/s40268-017-0221-9
UR  - http://hdl.handle.net/10668/11879
T2  - Drugs in R&D
AB  - Idiopathic pulmonary fibrosis is a fatal form of progressive fibrosing interstitial pneumonia with limited treatment options. In recent years, its management has been transformed with the approval of two new antifibrotic drugs: nintedanib and...
LA  - en
KW  - Disease Progression
KW  - Humans
KW  - Idiopathic Pulmonary Fibrosis
KW  - Indoles
KW  - Protein Kinase Inhibitors
TI  - Efficacy and Safety of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis: An Update.
TY  - research article
VL  - 18
ER  -